Evidence-based medicine research for the treatment of oral submucous fibrosis
Oral submucous fibrosis (OSF) is an oral potentially malignant disorader that may be closely related to betel chewing and other factors. The pathogenic mechanism of OSF is still unclear, and there is no cure for OSF. Currently, there are many clinical treatments for OSF, such as medications, includi...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Department of Journal of Prevention and Treatment for Stomatological Diseases
2024-12-01
|
| Series: | 口腔疾病防治 |
| Subjects: | |
| Online Access: | https://www.kqjbfz.com/fileup/2096-1456/PDF/2096-1456（2024）12-0907-09.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850251468587663360 |
|---|---|
| author | GUO Jincai, XIE Hui |
| author_facet | GUO Jincai, XIE Hui |
| author_sort | GUO Jincai, XIE Hui |
| collection | DOAJ |
| description | Oral submucous fibrosis (OSF) is an oral potentially malignant disorader that may be closely related to betel chewing and other factors. The pathogenic mechanism of OSF is still unclear, and there is no cure for OSF. Currently, there are many clinical treatments for OSF, such as medications, including steroids, pentoxifylline, lycopene, turmeric, salvia miltiorrhiza, and aloe vera, lasers, and surgery. In order to evaluate the safety and efficacy of these methods to improve the maximum mouth opening, alleviate the burning sensation, increase tongue flexibility, and other symptoms that accompany OSF, researchers have completed some evidence-based studies in recent years. We searched PubMed, Embase, Web of Science, The Cochrane Library, CNKI, Wanfang, and VIP databases for systematic reviews or meta-analyses of OSF research and treatment published over the last 10 years (July 2014-July 2024). Current evidence-based studies have shown that pentoxifylline, hyaluronidase combined with steroids, lycopene, curcumin, salvia miltiorrhiza combined with steroids, and aloe vera are effective in improving maximum mouth opening and alleviating the burning sensation in patients with OSF. The evidence levels of hyaluronidase combined with steroids, lycopene, curcumin, salvia miltiorrhiza combined with steroids, and aloe vera were all A, and pentoxifylline was B. Lycopene was more effective than other positive drugs in improving maximum mouth opening in patients, and aloe vera was more effective than positive drugs in improving the burning sensation in the early stage of treatment. In addition, antioxidants are good for improving OSF symptoms and have promising application. Lasers can improve maximum mouth opening and alleviate pain and other OSF symptoms, but laser treatment is costly and the level of evidence is C. Surgery is effective in improving maximum mouth opening, but it is traumatic and the level of evidence is C. However, the current evidence-based data are not of high quality, and additional well-designed multi-center, large-sample, randomized controlled clinical trials with long follow-up periods and standardized outcome indicators are needed in the future. |
| format | Article |
| id | doaj-art-01cb47dc79cd43889d32352da6e80508 |
| institution | OA Journals |
| issn | 2096-1456 |
| language | zho |
| publishDate | 2024-12-01 |
| publisher | Editorial Department of Journal of Prevention and Treatment for Stomatological Diseases |
| record_format | Article |
| series | 口腔疾病防治 |
| spelling | doaj-art-01cb47dc79cd43889d32352da6e805082025-08-20T01:57:54ZzhoEditorial Department of Journal of Prevention and Treatment for Stomatological Diseases口腔疾病防治2096-14562024-12-01321290791510.12016/j.issn.2096-1456.202440252Evidence-based medicine research for the treatment of oral submucous fibrosisGUO Jincai, XIE Hui01 Department of Pharmacy, Changsha Stomatological Hospital, Changsha 410006, China;2 School of Stomatology, Hunan University of Chinese Medicine, Changsha 410006, China;3 School of Pharmacy, Hunan University of Chinese Medicine, Changsha 410208, China;4 Department of Periodontal and Oral Mucosa, Changsha Stomatological Hospital, Changsha 410006, ChinaOral submucous fibrosis (OSF) is an oral potentially malignant disorader that may be closely related to betel chewing and other factors. The pathogenic mechanism of OSF is still unclear, and there is no cure for OSF. Currently, there are many clinical treatments for OSF, such as medications, including steroids, pentoxifylline, lycopene, turmeric, salvia miltiorrhiza, and aloe vera, lasers, and surgery. In order to evaluate the safety and efficacy of these methods to improve the maximum mouth opening, alleviate the burning sensation, increase tongue flexibility, and other symptoms that accompany OSF, researchers have completed some evidence-based studies in recent years. We searched PubMed, Embase, Web of Science, The Cochrane Library, CNKI, Wanfang, and VIP databases for systematic reviews or meta-analyses of OSF research and treatment published over the last 10 years (July 2014-July 2024). Current evidence-based studies have shown that pentoxifylline, hyaluronidase combined with steroids, lycopene, curcumin, salvia miltiorrhiza combined with steroids, and aloe vera are effective in improving maximum mouth opening and alleviating the burning sensation in patients with OSF. The evidence levels of hyaluronidase combined with steroids, lycopene, curcumin, salvia miltiorrhiza combined with steroids, and aloe vera were all A, and pentoxifylline was B. Lycopene was more effective than other positive drugs in improving maximum mouth opening in patients, and aloe vera was more effective than positive drugs in improving the burning sensation in the early stage of treatment. In addition, antioxidants are good for improving OSF symptoms and have promising application. Lasers can improve maximum mouth opening and alleviate pain and other OSF symptoms, but laser treatment is costly and the level of evidence is C. Surgery is effective in improving maximum mouth opening, but it is traumatic and the level of evidence is C. However, the current evidence-based data are not of high quality, and additional well-designed multi-center, large-sample, randomized controlled clinical trials with long follow-up periods and standardized outcome indicators are needed in the future.https://www.kqjbfz.com/fileup/2096-1456/PDF/2096-1456（2024）12-0907-09.pdforal submucous fibrosis|treatment|evidence-based medicine|steroids|salvia miltiorrhiza|pentoxifylline|hyaluronidase|lycopene|curcumin|aloe vera |
| spellingShingle | GUO Jincai, XIE Hui Evidence-based medicine research for the treatment of oral submucous fibrosis 口腔疾病防治 oral submucous fibrosis|treatment|evidence-based medicine|steroids|salvia miltiorrhiza|pentoxifylline|hyaluronidase|lycopene|curcumin|aloe vera |
| title | Evidence-based medicine research for the treatment of oral submucous fibrosis |
| title_full | Evidence-based medicine research for the treatment of oral submucous fibrosis |
| title_fullStr | Evidence-based medicine research for the treatment of oral submucous fibrosis |
| title_full_unstemmed | Evidence-based medicine research for the treatment of oral submucous fibrosis |
| title_short | Evidence-based medicine research for the treatment of oral submucous fibrosis |
| title_sort | evidence based medicine research for the treatment of oral submucous fibrosis |
| topic | oral submucous fibrosis|treatment|evidence-based medicine|steroids|salvia miltiorrhiza|pentoxifylline|hyaluronidase|lycopene|curcumin|aloe vera |
| url | https://www.kqjbfz.com/fileup/2096-1456/PDF/2096-1456（2024）12-0907-09.pdf |
| work_keys_str_mv | AT guojincaixiehui evidencebasedmedicineresearchforthetreatmentoforalsubmucousfibrosis |